awm, on 2013-June-05, 17:10, said:
If single payer govt plan increases options rather than being an impediment that is a very good thing. If it will allow for more trial and error in health care and thus failures that is a good thing.
However when I read about the recent 200 million for a new program that goes to just one company, rather than spread out among many, my first thought is crony capitalism.
U.S. Gives Glaxo Up To $200 Million for Antibiotic Research
Read more: http://www.nasdaq.co...8#ixzz2VO3YdSvQ